ERBB2 and breast carcinoma: Our bioinformatics analysis highlighted that high levels of C1q have a favorable prognostic index in BLBCs for DFS and HER2+ breast cancer for OS, (Graphical Abstract) consistent with the in vivo studies by Bandini et al. using C1q-deficient mice (25).